Coronavirus vaccine gets positive results in first human trial New York Post Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial CNBCEarly study of Covid-19 vaccine developed in China sees mixed results STATEarly Coronavirus Immunity Data Fuel Promise for a Vaccine Scientific AmericanSafety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial The LancetView Full Coverage on Google News